Most of these CNA were also reported in larger cohorts of CTCL patients, such as gains of 8q, harboring the MYC locus, or deletions of the TP53 locus on 17p (Fig 1A and Appendix Fig S2; Karenko et al, 2007; van Doorn et al, 2009; Laharanne et al, 2010; Salgado et al, 2010; Kiel et al, 2015; McGirt et al, 2015). This evidence concerns the gene TP53 and primary cutaneous T-cell non-Hodgkin lymphoma.